River Street Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.58M Buy
4,650
+39
+0.8% +$39.8K 1.64% 16
2026
Q1
$4.24M Buy
4,611
+93
+2% +$94.3K 1.43% 16
2025
Q4
$4.86M Buy
4,518
+8
+0.2% +$7.65K 1.82% 14
2025
Q3
$3.44M Buy
4,510
+947
+27% +$705K 1.33% 16
2025
Q2
$2.78M Buy
3,563
+387
+12% +$301K 1.2% 20
2025
Q1
$2.62M Buy
3,176
+7
+0.2% +$5.83K 1.3% 17
2024
Q4
$2.45M Buy
3,169
+20
+0.6% +$16.6K 1.25% 21
2024
Q3
$2.79M Sell
3,149
-17
-0.5% -$15.3K 1.51% 15
2024
Q2
$2.87M Sell
3,166
-351
-10% -$281K 1.76% 13
2024
Q1
$2.74M Buy
3,517
+5
+0.1% +$3.56K 1.85% 12
2023
Q4
$2.05M Buy
3,512
+53
+2% +$30.9K 1.63% 13
2023
Q3
$1.86M Sell
3,459
-24
-0.7% -$12.4K 1.75% 13
2023
Q2
$1.63M Sell
3,483
-117
-3% -$49.1K 1.56% 14
2023
Q1
$1.24M Buy
+3,600
New +$1.21M 1.22% 24

Other funds holding LLY

River Street Advisors's LLY Position: Q2 2026 in Review

River Street Advisors increased its Eli Lilly (LLY) stake by 0.85% in Q2 2026, buying an estimated $39.8K and bringing the position to 4,650 shares worth $5.58M. The position accounts for 1.64% of the portfolio, ranked #16.

River Street Advisors first reported a position in LLY in Q1 2023 and has held it in 14 quarters since. 1,558 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • River Street Advisors held 4,650 shares of Eli Lilly worth $5.58M as of Q2 2026.
  • River Street Advisors bought 39 Eli Lilly shares in Q2 2026, an estimated $39.8K.
  • Eli Lilly made up 1.64% of River Street Advisors's portfolio in Q2 2026, its #16 holding.
  • River Street Advisors first reported a position in Eli Lilly in Q1 2023 and has held it in 14 quarters since.
  • 1,558 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on River Street Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.